Costa Rica vs India: Reported rate of new cervical cancer cases
Costa Rica
11.71 per 100,000 women
in 2016
India
10.08 per 100,000 women
in 2017
Costa Rica rank
11th
India rank
14th
Reported rate of new cervical cancer cases over time
- Costa Rica
- India
How they compare
Costa Rica currently reports 11.71 per 100,000 women against 10.08 per 100,000 women in India, a difference of 1.63 per 100,000 women.
That makes Costa Rica's figure about 1.2 times India's.
The two have swapped places 4 times across 14 shared years of data; in 2003 it was Costa Rica ahead.
Costa Rica ranks 11th and India ranks 14th of 46 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.84 per 100,000 women | 16.18 per 100,000 women | 2.34 per 100,000 women | India |
| 2010s | 11.86 per 100,000 women | 11.97 per 100,000 women | 0.1066 per 100,000 women | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Costa Rica or India?
- Costa Rica, at 11.71 per 100,000 women against 10.08 per 100,000 women in India as of 2016.
- What is the difference in reported rate of new cervical cancer cases between Costa Rica and India?
- 1.63 per 100,000 women, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and India?
- 14 years are reported by both, from 2003 to 2016.
- How do Costa Rica and India rank globally for reported rate of new cervical cancer cases?
- Costa Rica ranks 11th and India ranks 14th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.